Search results for "ethanolamines"

showing 10 items of 65 documents

Liver fatty acid composition in the spontaneously diabetic BB rat.

1991

The purpose of the present experiment was to investigate if the modulation by insulin of liver microsomal desaturase activities in the spontaneously diabetic adult male Bio-Breeding (BB) rat, with destructive insulitis resembling the lesions described in the human Type I (insulin-dependent) diabetes, corresponds to modifications in fatty acid composition, reflect of changes in fatty acid desaturation. We observed no significant differences between BB rats, during the hyper-(48 h), the normo-(17 h) and the hypo-glycemic (3 h) periods which followed the insulin injection, and control rats for the fatty acid composition of liver total lipids, phosphatidylethanolamines, phosphatidylcholines, tr…

Fatty Acid DesaturasesMalemedicine.medical_specialtymedicine.medical_treatmentLinoleic acidArachidonic AcidsBiologyDiabetes Mellitus ExperimentalLinoleic Acidchemistry.chemical_compoundDiabetes mellitusInternal medicinemedicineAnimalsInsulinRats Inbred BBTriglycerideschemistry.chemical_classificationArachidonic AcidCholesterolInsulinPhosphatidylethanolaminesFatty AcidsFatty acidGeneral Medicinemedicine.diseaseLipid MetabolismRatsEndocrinologychemistryLinoleic AcidsLiverMicrosomeMicrosomes LiverPhosphatidylcholinesArachidonic acidCholesterol EstersInsulitisArchives internationales de physiologie, de biochimie et de biophysique
researchProduct

High-performance liquid chromatographic study of the regulation of phospholipid metabolism in cultured adrenocortical cells

1994

Abstract A rapid high-performance liquid chromatographic (HPLC) method for the separation of phospholipids was developed for minute samples of total lipids (ca. 200 μg). The method was applied to the study of the phospholipid metabolism in adrenocortical cell cultures. A complete separation of the different cellular phospholipid classes was achieved in 40 min. Good resolution of the phospholipid peaks was obtained, which allowed the collection of each individual class of phospholipids for further analysis of radioactivity and fatty acid composition by gas chromatography. When cells were incubated with [U-14C]glycerol or [U-14C]palmitate the bulk of the radioactivity was found in cellular ph…

GlycerolCardiolipinsPalmitatesPhospholipidHigh-performance liquid chromatographyMicechemistry.chemical_compoundTumor Cells CulturedGlycerolmedicineAnimalsCells CulturedChromatography High Pressure LiquidPhospholipidschemistry.chemical_classificationChromatographyAdrenal cortexPhosphatidylethanolaminesGeneral ChemistryMetabolismAdrenal Cortex NeoplasmsIn vitromedicine.anatomical_structurechemistryBiochemistryCell cultureAdrenal CortexPhosphatidylcholinesTetradecanoylphorbol AcetateIndicators and Reagentslipids (amino acids peptides and proteins)Polyunsaturated fatty acidJournal of Chromatography B: Biomedical Sciences and Applications
researchProduct

Identification of a putative membrane-inserted segment in the alpha-toxin of Staphylococcus aureus.

1994

To gain a fuller understanding of the regions of the Staphylococcus aureus alpha-toxin important in pore formation, we have used Forster dipole-dipole energy transfer to demonstrate that a central glycine-rich region of alpha-toxin (the so-called "hinge" region) inserts deeply into the bilayer on association of toxin with liposomes. Mutant alpha-toxins with unique cysteine (C) residues at positions 69 and 130 [Palmer, M., et al. (1993) J. Biol. Chem. 268, 11959) were reacted with the C-specific fluorophore acrylodan, which acted as an energy donor. The chosen acceptor was N-(7-nitrobenz-2-oxa-13- diazol-4-yl)-1,2-bis(hexadecanoyl)-sn-glycero-3-phosphoethanolamin e (NBD-PE). Measurement of t…

LiposomeStaphylococcus aureusQuenching (fluorescence)FluorophoreStereochemistryBilayerPhosphatidylethanolaminesBacterial ToxinsLipid BilayersMembrane ProteinsFluorescence PolarizationBiochemistryAcceptorLipidschemistry.chemical_compoundHemolysin ProteinsMembranechemistryMutagenesis Site-DirectedStaphylococcus aureus delta toxinCysteineFluorescent DyesBiochemistry
researchProduct

Bile acid amidoalcohols: simple organogelators.

2003

Simple bile acid amide synthesis of lithocholic and deoxycholic acids with 2-aminoethanol and 3-aminopropanol are reported. The structural properties of these amides were examined by NMR spectroscopic, ESI-TOF mass spectral, and X-ray crystallographic methods. The gelation properties of these amides in common organic solvents and in three different water solutions were also investigated using Tyndall effect, SEM, TEM, and optical microscopy. 2-Hydroxyethylamides were found to be effective gelators in chlorinated organic solvents and 3-hydroxypropylamides in aromatic solvents. Both derivatives thicken neutral and acidic water solutions.

Lithocholic acidTyndall effectmedicine.drug_classSurface PropertiesBiomedical EngineeringBiophysicsMolecular ConformationAlcoholBile Acids and SaltsPropanolamineschemistry.chemical_compoundPropanolaminesAmideElectrochemistrymedicineOrganic chemistryOrganic ChemicalsBile acidDeoxycholic acidEthanolaminesGeneral MedicinechemistryEthanolaminesLithocholic AcidGelsBiotechnologyDeoxycholic AcidBiosensorsbioelectronics
researchProduct

The influence of phase transitions in phosphatidylethanolamine models on the activity of violaxanthin de-epoxidase

2008

In the present study, the influence of the phospholipid phase state on the activity of the xanthophyll cycle enzyme violaxanthin de-epoxidase (VDE) was analyzed using different phosphatidylethanolamine species as model lipids. By using (31)P NMR spectroscopy, differential scanning calorimetry and temperature dependent enzyme assays, VDE activity could directly be related to the lipid structures the protein is associated with. Our results show that the gel (L beta) to liquid-crystalline (L alpha) phase transition in these single lipid component systems strongly enhances both the solubilization of the xanthophyll cycle pigment violaxanthin in the membrane and the activity of the VDE. This pha…

Magnetic Resonance SpectroscopyBiophysicsAnalytical chemistryPhospholipidMonogalactosyldiacylglycerolXanthophyllsBiochemistryViolaxanthin de-epoxidaseModels BiologicalPhase Transitionchemistry.chemical_compoundDifferential scanning calorimetrySpinacia oleraceaPhase (matter)31P NMRInverted hexagonal phaseDe-epoxidationchemistry.chemical_classificationPhosphatidylethanolaminePhospholipid structuresChemistryPhosphatidylethanolaminesTemperatureCell BiologyNuclear magnetic resonance spectroscopyLipid MetabolismSolubilityArrheniusXanthophyllBiophysicsOxidoreductasesViolaxanthinBiochimica et Biophysica Acta (BBA) - Biomembranes
researchProduct

Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines…

2016

Palmitoylethanolamide (PEA) is an endogenous lipid mediator known to reduce pain and inflammation. However, only limited clinical studies have evaluated the effects of PEA in neuroinflammatory and neurodegenerative diseases. Multiple sclerosis (MS) is a chronic autoimmune and inflammatory disease of the central nervous system. Although subcutaneous administration of interferon (IFN)-β1a is approved as first-line therapy for the treatment of relapsing–remitting MS (RR-MS), its commonly reported adverse events (AEs) such as pain, myalgia, and erythema at the injection site, deeply affect the quality of life (QoL) of patients with MS. In this randomized, double-blind, placebo-controlled study,…

Male0301 basic medicinemyalgiaErythemaAnti-Inflammatory AgentsPalmitic AcidAdministration OralPharmacologyGastroenterologychemistry.chemical_compound0302 clinical medicineNeuroinflammationFAAHEthanolaminePharmacology (medical)SkinInterleukin-17food and beveragesAnti-Inflammatory AgentTolerabilityEthanolaminesDisease ProgressionCytokinesOriginal ArticleFemalemedicine.symptomInterferon beta-1aHumanAdultmedicine.medical_specialtyPainPalmitic AcidsProinflammatory cytokineInterferon-gamma03 medical and health sciencesMultiple Sclerosis Relapsing-RemittingDouble-Blind MethodInternal medicinemedicineHumansAdverse effectCytokinePharmacologyPalmitoylethanolamideExpanded Disability Status ScaleTumor Necrosis Factor-alphabusiness.industryMultiple sclerosisN-acylethanolamineOleoylethanolamideAnandamideNAAAmedicine.diseaseAmides030104 developmental biologychemistryNeurology (clinical)business030217 neurology & neurosurgeryNeurotherapeutics
researchProduct

Effects of long-acting bronchodilators in COPD patients according to COPD severity and ICS use

2013

SummaryBackgroundIndacaterol is a once-daily, long-acting β2-agonist bronchodilator that improves dyspnoea and health status in patients with moderate-to-severe COPD. While its bronchodilator effects have been shown to be maintained in different patient subgroups, effects on clinical outcomes in certain subgroups are not yet defined.MethodsPost-hoc analysis of pooled clinical study data to investigate efficacy and safety of indacaterol compared with placebo and other long-acting bronchodilators (formoterol, salmeterol, open-label tiotropium) in patient subgroups defined by COPD severity (GOLD stage II or III; n = 4082) and ICS use at baseline (no/yes; n = 4088). Efficacy outcomes were troug…

MaleCopd patientsVital CapacityQuinolonesSeverity of Illness IndexPulmonary Disease Chronic ObstructiveForced Expiratory VolumeFormoterol FumarateBronchodilatorFormoterolSalmeterolSalmeterol XinafoateRandomized Controlled Trials as TopicIndacaterolCOPDMiddle AgedBronchodilator AgentsTreatment OutcomeEthanolaminesAnesthesiaIndansDrug Therapy CombinationFemaleSalmeterolmedicine.drugAdultPulmonary and Respiratory Medicinemedicine.medical_specialtymedicine.drug_classScopolamine DerivativesPlaceboDrug Administration ScheduleInternal medicineAdministration InhalationmedicineHumansCOPDAlbuterolTiotropium BromideAdrenergic beta-2 Receptor AgonistsGlucocorticoidsAgedbusiness.industryTiotropiummedicine.diseaserespiratory tract diseasesDyspneaLong actingIndacaterolFormoterolbusinessRespiratory Medicine
researchProduct

Erythrocyte Phospholipid and Polyunsaturated Fatty Acid Composition in Diabetic Retinopathy

2014

Background: Long chain polyunsaturated fatty acids (LCPUFAs) including docosahexaenoic acid and arachidonic acid are suspected to play a key role in the pathogenesis of diabetes. LCPUFAs are known to be preferentially concentrated in specific phospholipids termed as plasmalogens. This study was aimed to highlight potential changes in the metabolism of phospholipids, and particularly plasmalogens, and LCPUFAs at various stages of diabetic retinopathy in humans. Methodology and Principal Findings: We performed lipidomic analyses on red blood cell membranes from controls and mainly type 2 diabetes mellitus patients with or without retinopathy. The fatty acid composition of erythrocytes was det…

MaleOrganes des senslcsh:MedicineType 2 diabetesBiochemistrySeverity of Illness Indexchemistry.chemical_compoundMELLITUS0302 clinical medicineMedicine and Health SciencesMedicineOXIDATIVE STRESSlcsh:ScienceRETINAPhospholipidschemistry.chemical_classification0303 health sciencesCOMPLICATIONSMultidisciplinaryINSULIN SENSITIVITYFatty AcidsDiabetic retinopathyMiddle AgedLipids3. Good healthDocosahexaenoic acid[ SDV.MHEP.OS ] Life Sciences [q-bio]/Human health and pathology/Sensory OrgansFatty Acids UnsaturatedPhosphatidylcholinesRetinal DisordersArachidonic acidlipids (amino acids peptides and proteins)FemalePolyunsaturated fatty acidRetinopathyResearch ArticleEXPRESSIONAdultmedicine.medical_specialtySensory OrgansPlasmalogensPhospholipidMédecine humaine et pathologie030209 endocrinology & metabolism03 medical and health sciencesInternal medicineDiabetes mellitus[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyDiabetes MellitusHumans[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory OrgansRetinopathy030304 developmental biologyAgedDiabetic Retinopathybusiness.industryPhosphatidylethanolamineslcsh:RErythrocyte MembraneBiology and Life SciencesDOCOSAHEXAENOIC ACIDmedicine.diseaseLipid MetabolismENDOTHELIAL-CELLSDOCOSAHEXAENOIC ACID;INSULIN SENSITIVITY;ENDOTHELIAL-CELLS;OXIDATIVE STRESS;RETINA;LIPIDS;DEFORMABILITY;COMPLICATIONS;EXPRESSION;MELLITUSOphthalmologyEndocrinologyDiabetes Mellitus Type 1chemistryDiabetes Mellitus Type 2Metabolic DisordersCase-Control Studieslcsh:QHuman health and pathologybusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyDEFORMABILITYPLoS ONE
researchProduct

Noradrenaline depleting and blood pressure lowering activity of threo-corbadrine

1968

Abstract Threo-corbadrine caused a long-lasting depletion of noradrenaline in the heart and in mesenteric vessels and lowered the blood pressure of normal and renal hypertensive rats. It is suggested that threo-cobadrine decreases vascular tone by acting peripherally as a substitute adrenergic transmitter.

MalePharmacologymedicine.medical_specialtyHypertension RenalChromatography PaperChemistryInjections SubcutaneousAdrenergicBlood PressureMethylationRatsVascular tonePlethysmographyNorepinephrineEndocrinologyBlood pressureEthanolaminesLevonordefrinInternal medicinemedicineAnimalsPlethysmographFluorometryBlood pressure loweringEuropean Journal of Pharmacology
researchProduct

Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with mod…

2015

Background QVA149 is a once-daily (o.d.) inhaled dual bronchodilator containing a fixed-dose combination of the long-acting β2-agonist indacaterol and the long-acting muscarinic antagonist glycopyrronium for the treatment of COPD. The QUANTIFY study compared QVA149 with a free-dose bronchodilator combination of tiotropium plus formoterol (TIO+FOR) in improving health-related quality of life (HRQoL) of patients with COPD. Methods This multicentre, blinded, triple-dummy, parallel-group, non-inferiority study randomised patients aged ≥40 years with moderate-to-severe COPD (post-bronchodilator forced expiratory volume in 1 s (FEV1) ≥30% to <80% predicted) to QVA149 110/50 µg o.d. or TIO 18 µg o…

MalePulmonary and Respiratory MedicineVital capacitymedicine.drug_classChronic Obstructive Pulmonary DiseaseVital CapacityScopolamine DerivativesQuinolonesCOPD PharmacologyDrug Administration SchedulePulmonary Disease Chronic ObstructiveFEV1/FVC ratioDouble-Blind MethodQuality of lifeForced Expiratory VolumeFormoterol FumarateBronchodilatorHumansMedicine1506Tiotropium BromideAdrenergic beta-2 Receptor AgonistsAgedCOPDbusiness.industryMiddle Agedmedicine.diseaseGlycopyrrolateBronchodilator Agentsrespiratory tract diseasesDrug CombinationsTreatment OutcomeEthanolaminesBronchodilator AgentsAnesthesiaIndansQuality of LifeIndacaterolFemaleFormoterolbusinessmedicine.drugThorax
researchProduct